Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227155 · ClinicalTrials.gov registry record
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
A clinical trial, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 375
- Enrollment target
NCT07227155: Recruiting study, sponsored by Medical College of Wisconsin.
NCT07227155 is a clinical trial that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 375 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227155 is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 375 participants
- Enrollment target
Study Summary
A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood diseases.
Primary Outcome
Retention of biospecimen samples with DNA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2031-03-30 |
What NCT07227155 shows while recruiting
NCT07227155 is an observational study that tracks outcomes without assigning an intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT07227155 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07227155 about?
NCT07227155 is a clinical study titled "The HOPE Biobank Resource (BMT CTN 2402 HOPE)". A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood diseases.
What is the current status of trial NCT07227155?
This trial is currently recruiting. The enrollment target is 375 participants. The study started on 2026-05-15. Estimated completion is 2031-03-30.
Who is sponsoring clinical trial NCT07227155?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI